Growing burden of blood cancer instances round the globe have augmented significant progress in apt therapeutics development for blood cancer. Leading drug makers are keen on offering differentiated drugs such as precision medicine to offset blood cancer induced fatality. Additionally, active government funding for advanced therapeutics and diagnostics besides adequate reimbursement policies to reduce treatment costs are likely to foster growth in ... Read more
